|
Burcin Taner MD
Professor and Chair
Mayo Clinic
|
C. Burcin Taner, M.D., is a consultant and serves as chair for the Department of Transplant at Mayo Clinic in Florida and as the Mayo Clinic Enterprise Director for Transplant. Dr. Taner joined the staff of Mayo Clinic in 2007 and holds the academic rank of Professor of Surgery. In this role he oversees all practice, research and education activities of transplant programs at Mayo Clinic’s 3 destination campuses.
Dr. Taner earned his M.D. at Hacettepe University Medical School, Ankara, Turkey. He completed a residency and chief residency in surgery at Mayo Clinic. He subsequently completed a fellowship in transplantation surgery, also at Mayo Clinic.
Dr. Taner’s clinical interests are liver, kidney and pancreas transplantation; process improvement; and resource utilization in transplant surgery. His research focuses on liver transplant outcomes, ischemia reperfusion injury and early allograft dysfunction after liver transplantation, and liver transplantation using donation after cardiac death liver grafts. He consistently publishes in high-impact scientific journals and has held reviewer responsibilities for prominent publications.
In addition to his clinical and research activities, Dr. Taner is active in education, and he has provided mentorship to many research and surgical fellows, among others.
Dr. Taner’s memberships with professional organizations include the American Association for the Study of Liver Diseases, American Society of Transplant Surgeons, American Society of Transplantation, and the International Liver Transplantation Society.
Dr. Taner earned his M.D. at Hacettepe University Medical School, Ankara, Turkey. He completed a residency and chief residency in surgery at Mayo Clinic. He subsequently completed a fellowship in transplantation surgery, also at Mayo Clinic.
Dr. Taner’s clinical interests are liver, kidney and pancreas transplantation; process improvement; and resource utilization in transplant surgery. His research focuses on liver transplant outcomes, ischemia reperfusion injury and early allograft dysfunction after liver transplantation, and liver transplantation using donation after cardiac death liver grafts. He consistently publishes in high-impact scientific journals and has held reviewer responsibilities for prominent publications.
In addition to his clinical and research activities, Dr. Taner is active in education, and he has provided mentorship to many research and surgical fellows, among others.
Dr. Taner’s memberships with professional organizations include the American Association for the Study of Liver Diseases, American Society of Transplant Surgeons, American Society of Transplantation, and the International Liver Transplantation Society.